Rye grass tolerising peptide vaccine - Acambis

Drug Profile

Rye grass tolerising peptide vaccine - Acambis

Alternative Names: Hay fever vaccine - Acambis; PTL 0901

Latest Information Update: 17 Feb 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Acambis
  • Class
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Seasonal allergic rhinitis

Most Recent Events

  • 17 Feb 2000 A clinical study has been added to the Vaccines therapeutic trials section
  • 22 Nov 1999 Discontinued-II for Seasonal allergic rhinitis in United Kingdom (Intranasal)
  • 13 Oct 1999 SmithKline Beecham's option to license the rye grass tolerising peptide has now expired
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top